Clinical Trial Update: Accessing Mobility Using Wearable Sensors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mobility with wearable sensors in patients with COPD and related cardiopulmonary conditions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disease
• Heart Failure
• Restrictive Lung Disease

Snippet

Sponsor: Baylor College of Medicine | Conditions: COPD, Pulmonary Disease | Phase 1, Phase 2 | Status: WITHDRAWN